Inmune Bio, Inc. [INMB]

Source: 

Company Overview

Our objective is to develop and commercialize our product candidates to treat diseases where the innate immune system is not functioning normally and contributing to the patients disease. This can be in cancer where Natural Killer (NK) cells are inactive and contribute to a tumors evasion of the immune system and/or disease progression while expression of MUC4 and cells of the tumor microenvironment such as Myeloid Derived Suppressor Cells (MDSC) proliferate to protect the tumor from attack by the patients immune system or this can be other diseases such as neurologic and metabolic diseases where chronic inflammation results in innate immune system dysfunction and disease progression or infectious disease where cytokine storm causes a hypermetabolic state that causes the need to seek medical attention.